We use cookies for certain features and to improve your experience. See our Cookie Policy and Privacy Policy to learn more

Leafly

Shop legal, local weed.

Open
advertise on Leafly
ShopDeliveryDispensariesDealsStrainsBrandsProductsCBDDoctorsCannabis 101Social impact
  • Sign in
  • Create account
  • Strains
  • Shop
  • Shop
  • Delivery
  • Deals
  • Dispensaries
  • CBD Stores
  • Brands
  • Products
  • Learn
  • Cannabis 101
  • News
  • Leafly Learn
  • Science of cannabis
  • Doctors
  • Social impact
  • Lab partners
  • Download the Leafly App
  • Advertise on Leafly
    • Leafly.comUSA flag
    • Leafly.caCanadian flag
    • Leafly.deGerman flag
  • Help
  1. Home
  2. News
  3. Alan Brochstein, The Cannabis Capitalist
  • News
  • Cannabis 101
  • Growing
  • Strains & products
  • CBD
  • Politics
  • Health
  • Lifestyle
  • Science & tech
  • Industry
  • Reports
  • Canada
  • Podcasts
  • Leafly Lists
Alan Brochstein, The Cannabis Capitalist
Alan Brochstein, The Cannabis Capitalist
Alan Brochstein, CFA, covers the cannabis industry full time from Houston, running 420 Investor, a subscription-based service for those interested in publicly-traded cannabis stocks, and New Cannabis Ventures, a news and information platform that highlights promising companies and influential investors in the cannabis industry. Before focusing on the cannabis industry in 2013, Alan worked as an independent equity research analyst following two decades as a portfolio manager, trader, and analyst.

21 total articles - Page 1 of 3

  • Cannabis Stocks Are Soaring, and This Rally Is Based on Reality

    Alan Brochstein, The Cannabis Capitalist - Published on September 5, 2018

    Past price spikes have been driven by hope, fear, and wild speculation. This one’s different. Alan Brochstein explains why.

    Read more
  • How to Capitalize on Canada’s Cannabis Consolidation

    Alan Brochstein, The Cannabis Capitalist - Published on August 6, 2018

    With the adult use market opening in October, expect to see more mergers and acquisitions.

    Read more
  • As Big Companies Go Public, Cannabis Stock Markets Get Legit

    Alan Brochstein, The Cannabis Capitalist - Published on July 10, 2018

    The make-up of the publicly-traded cannabis sector has improved substantially, with some of the best-known operators and brands now embracing the public markets.

    Read more
  • Investing: These 16 Cannabis Companies Are Generating Revenue

    Alan Brochstein, The Cannabis Capitalist - Published on June 4, 2018

    Revenue isn’t the only metric to consider when investing. But it’s important—and these cannabis companies are producing it.

    Read more
  • You Can Invest in a Cannabis Mutual Fund—But Should You?

    Alan Brochstein, The Cannabis Capitalist - Published on May 14, 2018

    A number of cannabis mutual funds and ETFs have emerged in the last 18 months, but their records are spotty.

    Read more
  • Investing in Australia’s Cannabis Industry: 5 Companies to Watch

    Alan Brochstein, The Cannabis Capitalist - Published on April 30, 2018

    Australia’s emerging cannabis industry offers investors options to participate. Financial analyst Alan Brochstein weighs in.

    Read more
  • Friendlier Feds Change the Game for Cannabis Stocks

    Alan Brochstein, The Cannabis Capitalist - Published on April 16, 2018

    Trump’s Friday announcement of a more hands-off federal approach to legal cannabis sent stocks soaring. Here’s how to play it.

    Read more
  • Massachusetts Cannabis Investing: Where to Start

    Alan Brochstein, The Cannabis Capitalist - Published on April 2, 2018

    On July 1, Massachusetts is expected to open the first adult-use market on the East Coast. What are your investing options?

    Read more
  • Investing in California Cannabis: Five Options

    Alan Brochstein, The Cannabis Capitalist - Published on March 12, 2018

    California’s new adult-use market opens up new opportunities for investors.

    Read more
  • Investing in CBD Companies? Watch Out for These Warning Signs

    Alan Brochstein, The Cannabis Capitalist - Published on February 26, 2018

    Public interest in cannabidiol (CBD), the non-intoxicating cannabinoid, has skyrocketed in the past year. But not all CBD producers are the same.

    Read more
123


Stay In Touch

Receive updates on new products, special offers, and industry news.

Something went wrong, please try again.

By providing us with your email address, you agree to Leafly’s Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App StoreDownload Leafly Marijuana Reviews on Google Play

Business Solutions
  • List your store
  • List your CBD store
  • List your brand
  • List your practice
  • Business log in

About Leafly
  • About us
  • Careers
  • Newsroom
  • Investor relations
  • Contact us
  • FAQs
  • Accessibility

Dispensaries in
  • Los Angeles
  • Seattle
  • Portland
  • San Francisco
  • Toronto
  • Detroit

Privacy & Terms
  • Terms of use
  • Commercial terms of use
  • Privacy policy
  • Do not sell my personal information

* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.


© 2025 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.